Registro:

Referencias:

• Alkemade, H.A., van Vlijmen-Willems, I.M., van Haelst, U.J., van de Kerkhof, P.C., Schalkwijk, J., Demonstration of skin-derived antileukoproteinase (SKALP) and its target enzyme human leukocyte elastase in squamous cell carcinoma (1994) J Pathol, 174, pp. 121-129
• Alonso, D.F., Farias, E.F., Urtreger, A., Ladeda, V., Vidal, M.C., Bal De Kier Joffé, E., Characterization of F3II, a sarcomatoid mammary carcinoma cell line originated from a clonal subpopulation of a mouse adenocarcinoma (1996) J Surg Oncol, 62, pp. 288-297
• Amiano, N., Reiteri, R.M., Costa, M.J., Tateosian, N., Chuluyan, H.E., Immunotherapy with SLPI over-expressing mammary tumor cells decreases tumor growth (2011) Cancer Immunol Immunother, 60, pp. 895-900
• Bouchard, D., Morisset, D., Bourbonnais, Y., Tremblay, G.M., Proteins with whey-acidic-protein motifs and cancer (2006) Lancet Oncol, 7, pp. 167-174
• Cavarra, E., Lucattelli, M., Gambelli, F., Bartalesi, B., Fineschi, S., Szarka, A., Giannerini, F., Lungarella, G., Human SLPI inactivation after cigarette smoke exposure in a new in vivo model of pulmonary oxidative stress (2001) Am J Physiol Lung Cell Mol Physiol, 281, pp. L412-L417
• Cheng, W.L., Wang, C.S., Huang, Y.H., Liang, Y., Lin, P.Y., Hsueh, C., Wu, Y.C., Lin, K.H., Overexpression of a secretory leukocyte protease inhibitor in human gastric cancer (2008) Int J Cancer, 123, pp. 1787-1796
• Clauss, A., Lilja, H., Lundwall, A., The evolution of a genetic locus encoding small serine proteinase inhibitors (2005) Biochem Biophys Res Commun, 333, pp. 383-389
• Devoogdt, N., Hassanzadeh Ghassabeh, G., Zhang, J., Brys, L., De Baetselier, P., Revets, H., Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells (2003) Proc Natl Acad Sci USA, 100, pp. 5778-5782
• Devoogdt, N., Rasool, N., Hoskins, E., Simpkins, F., Tchabo, N., Kohn, E.C., Overexpression of protease inhibitor-dead secretory leukocyte protease inhibitor causes more aggressive ovarian cancer in vitro and in vivo (2009) Cancer Sci, 100, pp. 434-440
• Duke, R.C., Cohen, J.J., (1992) Morphological and biochemical assays of apoptosis. Current Protocols in Immunology, pp. 31711-131716. , Colgan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, editors. New York: Greene and Wiley-Interscience
• Gomez, S.A., Arguelles, C.L., Guerrieri, D., Tateosian, N.L., Amiano, N.O., Slimovich, R., Maffia, P.C., Chuluyan, H.E., Secretory leukocyte protease inhibitor: A secreted pattern recognition receptor for mycobacteria (2009) Am J Respir Crit Care Med, 179, pp. 247-253
• Guerrieri, D., Tateosian, N.L., Maffia, P.C., Reiteri, R.M., Amiano, N.O., Costa, M.J., Villalonga, X., Chuluyan, H.E., Serine leucocyte proteinase inhibitor-treated monocyte inhibits human CD4 (+) lymphocyte proliferation (2011) Immunology, 133, pp. 434-441
• Hiemstra, P.S., Novel roles of protease inhibitors in infection and inflammation (2002) Biochem Soc Trans, 30, pp. 116-120
• Hough, C.D., Cho, K.R., Zonderman, A.B., Schwartz, D.R., Morin, P.J., Coordinately up-regulated genes in ovarian cancer (2001) Cancer Res, 61, pp. 3869-3876
• Hu, Y., Sun, H., Drake, J., Kittrell, F., Abba, M.C., Deng, L., Gaddis, S., Aldaz, C.M., From mice to humans: Identification of commonly deregulated genes in mammary cancer via comparative SAGE studies (2004) Cancer Res, 64, pp. 7748-7755
• Huang, C., Tang, H., Zhang, W., She, X., Liao, Q., Li, X., Wu, M., Li, G., Integrated analysis of multiple gene expression profiling datasets revealed novel gene signatures and molecular markers in nasopharyngeal carcinoma (2012) Cancer Epidemiol Biomarkers Prev, 21, pp. 166-175
• Iacobuzio-Donahue, C.A., Ashfaq, R., Maitra, A., Adsay, N.V., Shen-Ong, G.L., Berg, K., Hollingsworth, M.A., Hruban, R.H., Highly expressed genes in pancreatic ductal adenocarcinomas: A comprehensive characterization and comparison of the transcription profiles obtained from three major technologies (2003) Cancer Res, 63, pp. 8614-8622
• Israeli, O., Goldring-Aviram, A., Rienstein, S., Ben-Baruch, G., Korach, J., Goldman, B., Friedman, E., In silico chromosomal clustering of genes displaying altered expression patterns in ovarian cancer (2005) Cancer Genet Cytogenet, 160, pp. 35-42
• Jarzab, B., Wiench, M., Fujarewicz, K., Simek, K., Jarzab, M., Oczko-Wojciechowska, M., Wloch, J., Swierniak, A., Gene expression profile of papillary thyroid cancer: Sources of variability and diagnostic implications (2005) Cancer Res, 65, pp. 1587-1597
• Kluger, H.M., Kluger, Y., Gilmore-Hebert, M., DiVito, K., Chang, J.T., Rodov, S., Mironenko, O., Sapi, E., cDNA microarray analysis of invasive and tumorigenic phenotypes in a breast cancer model (2004) Lab Invest, 84, pp. 320-331
• Lentsch, A.B., Jordan, J.A., Czermak, B.J., Diehl, K.M., Younkin, E.M., Sarma, V., Ward, P.A., Inhibition of NF-kappaB activation and augmentation of IkappaBbeta by secretory leukocyte protease inhibitor during lung inflammation (1999) Am J Pathol, 154, pp. 239-247
• Liang, G., Gonzales, F.A., Jones, P.A., Orntoft, T.F., Thykjaer, T., Analysis of gene induction in human fibroblasts and bladder cancer cells exposed to the methylation inhibitor 5-aza-2'-deoxycytidine (2002) Cancer Res, 62, pp. 961-966
• Maffia, P.C., Zittermann, S.E., Scimone, M.L., Tateosian, N., Amiano, N., Guerrieri, D., Lutzky, V., Chuluyan, H.E., Neutrophil elastase converts human immature dendritic cells into transforming growth factor-beta1-secreting cells and reduces allostimulatory ability (2007) Am J Pathol, 171, pp. 928-937
• Mulligan, M.S., Lentsch, A.B., Huber-Lang, M., Guo, R.F., Sarma, V., Wright, C.D., Ulich, T.R., Ward, P.A., Anti-inflammatory effects of mutant forms of secretory leukocyte protease inhibitor (2000) Am J Pathol, 156, pp. 1033-1039
• Nakamura, K., Takamoto, N., Hongo, A., Kodama, J., Abrzua, F., Nasu, Y., Kumon, H., Hiramatsu, Y., Secretory leukoprotease inhibitor inhibits cell growth through apoptotic pathway on ovarian cancer (2008) Oncol Rep, 19, pp. 1085-1091
• Rein, D.T., Breidenbach, M., Nettelbeck, D.M., Kawakami, Y., Siegal, G.P., Huh, W.K., Wang, M., Curiel, D.T., Evaluation of tissue-specific promoters in carcinomas of the cervix uteri (2004) J Gene Med, 6, pp. 1281-1289
• Sallenave, J.M., Secretory leukocyte protease inhibitor and elafin/trappin-2: Versatile mucosal antimicrobials and regulators of immunity (2010) Am J Respir Cell Mol Biol, 42, pp. 635-643
• Simpkins, F., Devoogdt, N., Rasool, N., Tchabo, N., Alejandro, E., Kamrava, M., Kohn, E.C., The alarm anti-protease, secretory leukocyte protease inhibitor, is a proliferation and survival factor for ovarian cancer cells (2008) Carcinogenesis, 29, pp. 466-472
• Sriuranpong, V., Mutirangura, A., Gillespie, J.W., Patel, V., Amornphimoltham, P., Molinolo, A.A., Kerekhanjanarong, V., Gutkind, J.S., Global gene expression profile of nasopharyngeal carcinoma by laser capture microdissection and complementary DNA microarrays (2004) Clin Cancer Res, 10, pp. 4944-4958
• Stoff-Khalili, M.A., Stoff, A., Rivera, A.A., Banerjee, N.S., Everts, M., Young, S., Siegal, G.P., Curiel, D.T., Preclinical evaluation of transcriptional targeting strategies for carcinoma of the breast in a tissue slice model system (2005) Breast Cancer Res, 7, pp. R1141-R1152
• Sugino, T., Yamaguchi, T., Ogura, G., Kusakabe, T., Goodison, S., Homma, Y., Suzuki, T., The secretory leukocyte protease inhibitor (SLPI) suppresses cancer cell invasion but promotes blood-borne metastasis via an invasion-independent pathway (2007) J Pathol, 212, pp. 152-160
• Thompson, R.C., Ohlsson, K., Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase (1986) Proc Natl Acad Sci USA, 83, pp. 6692-6696
• Tsukishiro, S., Suzumori, N., Nishikawa, H., Arakawa, A., Suzumori, K., Use of serum secretory leukocyte protease inhibitor levels in patients to improve specificity of ovarian cancer diagnosis (2005) Gynecol Oncol, 96, pp. 516-519
• Urtreger, A.J., Diament, M.J., Ranuncolo, S.M., Del, C., Vidal, M., Puricelli, L.I., Klein, S.M., De Kier Joffe, E.D., New murine cell line derived from a spontaneous lung tumor induces paraneoplastic syndromes (2001) Int J Oncol, 18, pp. 639-647
• Wang, N., Thuraisingam, T., Fallavollita, L., Ding, A., Radzioch, D., Brodt, P., The secretory leukocyte protease inhibitor is a type 1 insulin-like growth factor receptor-regulated protein that protects against liver metastasis by attenuating the host proinflammatory response (2006) Cancer Res, 66, pp. 3062-3070
• Wen, J., Nikitakis, N.G., Chaisuparat, R., Greenwell-Wild, T., Gliozzi, M., Jin, W., Adli, A., Wahl, S.M., Secretory leukocyte protease inhibitor (SLPI) expression and tumor invasion in oral squamous cell carcinoma (2011) Am J Pathol, 178, pp. 2866-2878
• Westin, U., Nystrom, M., Ljungcrantz, I., Eriksson, B., Ohlsson, K., The presence of elafin, SLPI, IL1-RA and STNFalpha RI in head and neck squamous cell carcinomas and their relation to the degree of tumour differentiation (2002) Mediators Inflamm, 11, pp. 7-12
• Williams, S.E., Brown, T.I., Roghanian, A., Sallenave, J.M., SLPI and elafin: One glove, many fingers (2006) Clin Sci (Lond), 110, pp. 21-35
• Wright, C.D., Kennedy, J.A., Zitnik, R.J., Kashem, M.A., Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor (1999) Biochem Biophys Res Commun, 254, pp. 614-617
• Zhang, D., Simmen, R.C., Michel, F.J., Zhao, G., Vale-Cruz, D., Simmen, F.A., Secretory leukocyte protease inhibitor mediates proliferation of human endometrial epithelial cells by positive and negative regulation of growth-associated genes (2002) J Biol Chem, 277, pp. 29999-30009

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------